Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria.
Publication
, Journal Article
Jaffe, GJ; Pavesio, CE
Published in: J Ophthalmic Inflamm Infect
September 14, 2022
Duke Scholars
Published In
J Ophthalmic Inflamm Infect
DOI
ISSN
1869-5760
Publication Date
September 14, 2022
Volume
12
Issue
1
Start / End Page
30
Location
Germany
Related Subject Headings
- 3212 Ophthalmology and optometry
Citation
APA
Chicago
ICMJE
MLA
NLM
Jaffe, G. J., & Pavesio, C. E. (2022). Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria. J Ophthalmic Inflamm Infect, 12(1), 30. https://doi.org/10.1186/s12348-022-00307-0
Jaffe, Glenn J., and Carlos E. Pavesio. “Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria.” J Ophthalmic Inflamm Infect 12, no. 1 (September 14, 2022): 30. https://doi.org/10.1186/s12348-022-00307-0.
Jaffe GJ, Pavesio CE. Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria. J Ophthalmic Inflamm Infect. 2022 Sep 14;12(1):30.
Jaffe, Glenn J., and Carlos E. Pavesio. “Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria.” J Ophthalmic Inflamm Infect, vol. 12, no. 1, Sept. 2022, p. 30. Pubmed, doi:10.1186/s12348-022-00307-0.
Jaffe GJ, Pavesio CE. Recurrence rates in ocular non-infectious uveitis according to US FDA criteria or Rest of World criteria. J Ophthalmic Inflamm Infect. 2022 Sep 14;12(1):30.
Published In
J Ophthalmic Inflamm Infect
DOI
ISSN
1869-5760
Publication Date
September 14, 2022
Volume
12
Issue
1
Start / End Page
30
Location
Germany
Related Subject Headings
- 3212 Ophthalmology and optometry